Sub Banner Image

Here's Why You Should Retain AMED Stock in Your Portfolio for Now

Equities

Zacks Investment Research, Inc.

·

June 13, 2025

·

Barchart

Amedisys’ AMED valuable partnerships and acquisitions are expected to generate significant synergies in the upcoming quarters. The company’s continuously improving clinical quality for patients is demonstrated through its high Quality of Patient Care and Patient Satisfaction star ratings. However, a dull macroeconomic scenario and fierce competitive pressure may restrict Amedisys’...

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.